Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa
1 other identifier
observational
300
1 country
1
Brief Summary
This study looks at how well one antibiotic (monotherapy) works compared to two antibiotics (combination therapy) in treating bone infections caused by Pseudomonas aeruginosa. It includes 300 adult patients who had this type of infection confirmed by lab tests and medical imaging. The goal is to find out if using just one antibiotic is as effective as using two, while also looking at side effects, the need for more surgery, antibiotic resistance, and overall antibiotic use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2025
CompletedFirst Submitted
Initial submission to the registry
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedJuly 9, 2025
June 1, 2025
1 year
June 30, 2025
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical cure rate at the end of antibiotic treatment, defined as resolution of signs and symptoms of infection without need for additional antibiotic therapy or surgical intervention.
6 weeks
Eligibility Criteria
Participants will be selected from the electronic health records of adult patients hospitalized within the AP-HP (Assistance Publique-Hôpitaux de Paris) network. The study population includes individuals diagnosed with osteitis or osteomyelitis who have a confirmed microbiological diagnosis of Pseudomonas aeruginosa infection, along with imaging consistent with bone infection.
You may qualify if:
- Adult patients (≥18 years old)
- Diagnosis of osteitis or osteomyelitis due to Pseudomonas aeruginosa
- Isolation of Pseudomonas aeruginosa from at least one deep, sterile sample (e.g., bone biopsy, joint aspiration)
- Imaging findings consistent with osteomyelitis (MRI, CT scan, or X-ray)
You may not qualify if:
- No isolation of Pseudomonas aeruginosa
- No imaging evidence suggestive of osteomyelitis
- Patients under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Saint-Denis
Saint-Denis, France, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 9, 2025
Study Start
April 11, 2025
Primary Completion
April 15, 2026
Study Completion
April 15, 2026
Last Updated
July 9, 2025
Record last verified: 2025-06